Comparison of spirapril, isradipine, or combination in hypertensive patients with left ventricular hypertrophy: Effects on LVH regression and arrhythmogenic propensity

American Journal of Hypertension

Volumn 11, Issue 6 I, 1998, Pages 640-648

  Manolis, Athanasios J ^a   Beldekos, Demetrios ^a   Handanis, Stelios ^a   Haralabidis, Gavrilos ^a   Hatzissavas, John ^a   Foussas, Stephanos ^a   Cokkinos, Dennis V ^a   Bresnahan, Margaret ^b   Gavras, Irene ^b   Gavras, Haralambos ^b  

^a TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ambulatory electrocardiogram monitoring; Echocardiography; Exercise tolerance; Regression of left ventricular hypertrophy

Indexed keywords

ANGIOTENSIN; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ISRADIPINE; NORADRENALIN; SPIRAPRIL;

ARRHYTHMOGENESIS; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXERCISE TOLERANCE; FEMALE; HEART ELECTROPHYSIOLOGY; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE SIZE; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; ARRHYTHMIA; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; DOUBLE-BLIND METHOD; ENALAPRIL; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; ISRADIPINE; MALE;

EID: 0031839290     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(98)00036-3     Document Type: Article

References (30)

1. Savage D.D., Drayer J.I., Henry W.L., et al. Echocardiographic assessment of cardiac anatomy and function in hypertensive subjects. Circulation. 59:1979;623-632.
2. Levy D., Garrison R.J., Savage D.D., et al. Prognostic implications of echocardiographically determined left ventricular mass in subjects in the Framingham Heart Study. N Engl J Med. 332:1990;1561-1566.
3. Levy D., Anderson K.M., Savage D.D., et al. Risk of ventricular arrhythmias in left ventricular hypertrophy (The Framingham Heart Study). Am J Cardiol. 60:1987;560-565.
4. Beznak M., Korecky B., Thomas G. Regression of cardiac hypertrophies of various origin. Can J Physiol Pharmacol. 47:1969;579-586.
5. Pfeffer M.A., Pfeffer J.M. Reversing cardiac hypertrophy in hypertension. N Engl J Med. 322:1990;1388-1390.
6. Bruce R.A., Hornstein T.R. Exercise stress testing in evaluation of patients with ischemic heart disease. Prog Cardiovasc Dis. 11:1979;371-390.
7. Sealey J.E., Gerten-Bases J., Laragh J.H. The renin system variations in man measured by radioimmunoassay or bioassay . Kidney Int. 1:1972;240-253.
8. Davis G.C., Kissinger P.T., Sharp R.E. Strategies for determination of serum or plasma norepinephrine by reverse phase liquid chromotography. Anal Chem. 53:1981;156-159.
9. LaRochelle F.T. Jr, North W.G., Stern P. A new extraction of arginine vasopressin from blood the use of octadecasilysilica . Pflügers Archiv. 387:1980;79-89.
10. Sahn D.J., DeMaria A., Kisslo J., Weyman A. Recommendations regarding quantitation in M-mode echocardiography results of a survey of echocardiographic methods . Circulation. 58:1978;1072-1083.
11. O'Brien Mee F., Atkins N., O'Malley K. Accuracy of the SpaceLabs 90207 determined by the British Hypertension Society protocol. J Hypertens. 9:1991;573-574.
12. Romhilt D.W., Estes E.H. A point score system for the ECG diagnosis of left ventricular hypertrophy. Am Heart J. 75:1968;752-758.
13. Dollar A., Roberts W.C. Usefulness of total 12-lead QRS voltage compared with other criteria for determining left ventricular hypertrophy in hypertrophic cardiomyopathy analysis of 57 patients studies at necropsy . Am J Med. 87:1989;377-381.
14. Lown B., Wolf M. Approaches to sudden death from coronary heart disease. Circulation. 46:1971;130-142.
15. Maccariello E.R., Genelhu de Abreu Fagundes V., Francischetti E.A. The effects of isradipine and spirapril as monotherapy and combined therapy on blood pressure, renal hemodynamics, natriuresis, and urinary kallikrein in hypertensive nephropathy. Am J Hypertens. 10:1997;541-545.
16. Tarazi R.C., Fouad F.M. Reversal of cardiac hypertrophy in humans. Hypertension. 6:1984;140-146.
17. Thurmann N.S., Heagerty A.M., Kenedi P., et al. Influence of isradipine and spirapril on left ventricular hypertrophy and resistance arteries. Hypertension. 28:1996;450-456.
18. Manolis A.J., Kolovou G., Handanis S., et al. Regression of left ventricular hypertrophy with isradipine in previously untreated hypertensive patients. Am J Hypertens. 6:1993;86S-88S.
19. Sugishita Y., Iida K., Yukisada K., et al. Cardiac determinants of regression of left ventricular hypertrophy in essential hypertension with antihypertensive treatment. J Am Coll Cardiol. 15:1990;665-671.
20. Frohlich E.D., Tarazi R.C. Is arterial pressure the sole factor responsible for hypertensive cardiac hypertrophy? Am J Cardiol. 44:1979;959-963.
21. Daemen M.J.A.P., Lombardi D.M., Bosman F.T., Schwartz S.M. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res. 68:1991;450-456.
22. Newling R.P., Fletcher P.J., Contis M., Shaw J. Noradrenaline and cardiac hypertrophy in the rat changes in morphology, blood pressure and ventricular performance . J Hypertens. 7:1989;561-567.
23. Ferguson R.K., Turini G.A., Brunner H.R., Gavras H. A specific orally active inhibitor of angiotensin-converting enzyme in man. Lancet. i:1977;775-778.
24. Manolis A., Athanasopoulos G., Karatasakis G., et al. Pressor hormone profile during stress in hypertension does vasopressin interfere with left ventricular hypertrophy? Clin Exp Hypertens. 15:1993;539-555.
25. Schulman S.P., Weiss J.L., Becker L.C., et al. The effects of antihypertensive therapy on left ventricular mass in elderly patients. N Engl J Med. 322:1990;1350-1356.
26. TenEick R.E., Houser S.R., Bassett A.L. Cardiac hypertrophy and altered cellular electrical activity of the myocardium: possible electrophysiological basis for myocardial contractility changes. Sperelakis N. Physiology and Pathophysiology of the Heart. 2nd ed. 1989;57-94 Kluwer Academic, Boston.
27. McLenachan J.M., Henderson E., Morris K.I., Dargie H.J. Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. N Engl J Med. 317:1987;787-792.
28. Ghali J.K., Kadakia S., Cooper R.S., Youlian L. Impact of left ventricular hypertrophy on ventricular arrhythmias in the absence of coronary artery disease. J Am Coll Cardiol. 17:1991;1277-1282.
29. Kannel W.B., Doyle J.T., McNamara P.M., et al. Precursors of sudden death factors related to the incidence of sudden death . Circulation. 51:1975;606-613.
30. Brachmann J., Hilbel T., Schweizer M., Kubler W. Cardiac late potentials for diagnosis in heart disease. Eur Hrt J. 14:(suppl C):1993;49-51.